Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal.
about
Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Olaratumab in Combination with ...... e Single Technology Appraisal.
@en
Olaratumab in Combination with ...... e Single Technology Appraisal.
@nl
type
label
Olaratumab in Combination with ...... e Single Technology Appraisal.
@en
Olaratumab in Combination with ...... e Single Technology Appraisal.
@nl
prefLabel
Olaratumab in Combination with ...... e Single Technology Appraisal.
@en
Olaratumab in Combination with ...... e Single Technology Appraisal.
@nl
P2093
P2860
P50
P1433
P1476
Olaratumab in Combination with ...... ce Single Technology Appraisal
@en
P2093
Fiona C Warren
James Dunham
Peter Stephens
Tracey Jones-Hughes
P2860
P2888
P356
10.1007/S40273-017-0568-3
P577
2018-01-01T00:00:00Z